Testing effectiveness (Phase 2)UnknownNCT00295425What this trial is testingCYA Versus MMF for Treatment of Moderate-Severe Psoriasis.Who this might be right forPsoriasis University Hospital Muenster 50
Post-approval studies (Phase 4)Ended earlyNCT01543204What this trial is testingEtanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to AdalimumabWho this might be right forPsoriasis Amgen 64
Testing effectiveness (Phase 2)Study completedNCT00428974What this trial is testingSafety and Efficacy Study of CF101 to Treat PsoriasisWho this might be right forPlaque Psoriasis Can-Fite BioPharma 76
Testing effectiveness (Phase 2)Study completedNCT01483599What this trial is testingEvaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type PsoriasisWho this might be right forPsoriasis Janssen Inc. 293
Not applicableUnknownNCT02174367What this trial is testingAn Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe PsoriasisWho this might be right forPsoriasis ChronicLiver FibrosisFatty Liver+1 more King's College London 400
Post-approval studies (Phase 4)Study completedNCT00936065What this trial is testingStudy Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe PsoriasisWho this might be right forModerate to Severe Psoriasis Pfizer 60
Not applicableActive Not RecruitingNCT06142357What this trial is testingSecukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With PsoriasisWho this might be right forModerate-to-severe Plaque Psoriasis Novartis Pharmaceuticals 199
Post-approval studies (Phase 4)UnknownNCT03307447What this trial is testingSecukinumab Therapy for the Treatment of Moderate to Severe Plaque Psoriasis With Response Monitoring Using Optical Coherence Tomography (OCT).Who this might be right forPsoriasis Vulgaris Narrows Institute for Biomedical Research 30
Testing effectiveness (Phase 2)Study completedNCT06061471What this trial is testingTo Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasisSkin Diseases Akeso 454
Very early researchLooking for participantsNCT07337434What this trial is testingTo Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care HospitalWho this might be right forChronic Plaque Psoriasis Syeda Sana Zaman 106
Early research (Phase 1)Study completedNCT01276847What this trial is testingAssess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206)Who this might be right forPsoriasis Merck Sharp & Dohme LLC 40
Not applicableStudy completedNCT03511755What this trial is testing12-Week Study Assessing Change in Psoriasis Severity and Level of Stress Using TENWho this might be right forPsoriasisStress Thync Global, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT02576678What this trial is testingSafety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Amgen 42
Not applicableStudy completedNCT00769184What this trial is testingCombining Topical Corticosteroid and LCD Treatment for Localized Plaque PsoriasisWho this might be right forPsoriasis NeoStrata Company, Inc. 15
Large-scale testing (Phase 3)UnknownNCT06477237What this trial is testingStudy of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Huabo Biopharm Co., Ltd. 400
Large-scale testing (Phase 3)Study completedNCT04123795What this trial is testingEvaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forModerate Chronic Plaque PsoriasisSevere Chronic Plaque PsoriasisMixed Guttate/Plaque Psoriasis UCB Biopharma SRL 49
Not applicableStudy completedNCT01435265What this trial is testingNurse Education in Subjects With Psoriasis Undergoing Treatment With AdalimumabWho this might be right forPsoriasis Wake Forest University Health Sciences 7
Large-scale testing (Phase 3)Study completedNCT02698475What this trial is testingAn Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of AgeWho this might be right forPsoriasis Janssen Research & Development, LLC 44
Large-scale testing (Phase 3)Study completedNCT04453137What this trial is testingPharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPlaque Psoriasis Alvotech Swiss AG 567
Testing effectiveness (Phase 2)Study completedNCT01132612What this trial is testingAIN457 Regimen Finding Extension Study in Participants With Moderate to Severe PsoriasisWho this might be right forPlaque-type Psoriasis Novartis Pharmaceuticals 275